A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 247,896 shares of ZTS stock, worth $41 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
247,896
Previous 253,869 2.35%
Holding current value
$41 Million
Previous $44 Million 10.05%
% of portfolio
0.15%
Previous 0.14%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$172.58 - $196.48 $1.03 Million - $1.17 Million
-5,973 Reduced 2.35%
247,896 $48.4 Million
Q2 2024

Jul 22, 2024

SELL
$145.54 - $178.83 $750,695 - $922,405
-5,158 Reduced 1.99%
253,869 $44 Million
Q1 2024

May 03, 2024

SELL
$165.67 - $199.94 $419,807 - $506,647
-2,534 Reduced 0.97%
259,027 $43.8 Million
Q4 2023

Jan 24, 2024

SELL
$151.44 - $200.09 $352,098 - $465,209
-2,325 Reduced 0.88%
261,561 $51.6 Million
Q3 2023

Oct 23, 2023

SELL
$167.14 - $192.77 $1.17 Million - $1.35 Million
-7,003 Reduced 2.59%
263,886 $45.9 Million
Q2 2023

Jul 25, 2023

SELL
$160.94 - $186.23 $804,700 - $931,150
-5,000 Reduced 1.81%
270,889 $46.6 Million
Q1 2023

May 17, 2023

BUY
$145.48 - $175.02 $38.9 Million - $46.8 Million
267,554 Added 3210.01%
275,889 $45.9 Million
Q1 2023

May 15, 2023

SELL
$145.48 - $175.02 $38.5 Million - $46.3 Million
-264,773 Reduced 96.95%
8,335 $1.39 Billion
Q4 2022

Feb 09, 2023

SELL
$131.14 - $157.47 $2.31 Million - $2.78 Million
-17,650 Reduced 6.07%
273,108 $40 Million
Q3 2022

Nov 04, 2022

BUY
$148.29 - $182.55 $202,119 - $248,815
1,363 Added 0.47%
290,758 $43.1 Million
Q2 2022

Aug 10, 2022

SELL
$155.97 - $200.09 $37,588 - $48,221
-241 Reduced 0.08%
289,395 $49.7 Million
Q1 2022

Apr 27, 2022

BUY
$181.39 - $234.03 $30,473 - $39,317
168 Added 0.06%
289,636 $54.6 Million
Q4 2021

Jan 31, 2022

SELL
$193.69 - $247.03 $1.41 Million - $1.8 Million
-7,304 Reduced 2.46%
289,468 $70.6 Million
Q3 2021

Oct 20, 2021

SELL
$189.29 - $209.69 $2.25 Million - $2.5 Million
-11,907 Reduced 3.86%
296,772 $57.6 Million
Q2 2021

Jul 20, 2021

SELL
$155.9 - $187.99 $2.54 Million - $3.07 Million
-16,322 Reduced 5.02%
308,679 $57.5 Million
Q1 2021

Apr 22, 2021

SELL
$144.0 - $169.39 $3.94 Million - $4.63 Million
-27,361 Reduced 7.77%
325,001 $51.2 Million
Q4 2020

Feb 12, 2021

SELL
$157.07 - $174.35 $1.18 Million - $1.31 Million
-7,539 Reduced 2.09%
352,362 $58.3 Million
Q3 2020

Nov 06, 2020

SELL
$137.1 - $165.37 $4.21 Million - $5.08 Million
-30,691 Reduced 7.86%
359,901 $59.5 Million
Q2 2020

Aug 14, 2020

SELL
$111.92 - $142.53 $2.52 Million - $3.21 Million
-22,546 Reduced 5.46%
390,592 $53.5 Million
Q1 2020

May 13, 2020

BUY
$92.66 - $144.94 $611,370 - $956,314
6,598 Added 1.62%
413,138 $48.6 Million
Q4 2019

Feb 12, 2020

SELL
$116.25 - $133.25 $43,942 - $50,368
-378 Reduced 0.09%
406,540 $53.8 Million
Q3 2019

Nov 20, 2019

BUY
$112.57 - $128.43 $114,033 - $130,099
1,013 Added 0.25%
406,918 $50.7 Million
Q2 2019

Aug 14, 2019

BUY
$97.98 - $114.28 $30,275 - $35,312
309 Added 0.08%
405,905 $46.1 Million
Q1 2019

May 13, 2019

BUY
$81.56 - $100.67 $326,240 - $402,680
4,000 Added 1.0%
405,596 $41.3 Million
Q4 2018

Feb 14, 2019

SELL
$79.28 - $95.27 $218,654 - $262,754
-2,758 Reduced 0.68%
401,596 $34.4 Million
Q3 2018

Oct 23, 2018

SELL
$83.5 - $93.23 $963,423 - $1.08 Million
-11,538 Reduced 2.77%
404,354 $37 Million
Q2 2018

Aug 02, 2018

SELL
$79.9 - $89.2 $366,341 - $408,982
-4,585 Reduced 1.09%
415,892 $35.4 Million
Q1 2018

Apr 10, 2018

SELL
$71.51 - $84.69 $514,514 - $609,344
-7,195 Reduced 1.68%
420,477 $35.1 Million
Q4 2017

Jan 22, 2018

SELL
$63.24 - $72.8 $375,392 - $432,140
-5,936 Reduced 1.37%
427,672 $30.8 Million
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $25.9 Million - $28.4 Million
433,608
433,608 $27.6 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.